Core Insights - CreateAI's upcoming open-world RPG, Heroes of Jin Yong, has won the Platinum award at the 2025 Pinnacle Awards, highlighting its status as a category benchmark in the gaming industry [1][2] - The game is recognized for its strong intellectual property foundation, advanced production pipeline, and innovative take on Wuxia culture, marking a significant achievement in the AAA gaming sector [2] Company Overview - CreateAI is a global applied artificial intelligence company with a focus on digital entertainment, operating in the US, China, and Japan [5] - The company aims to redefine digital storytelling through the integration of generative AI technology and creative talent, enhancing the immersive experience for global audiences [5] Product Details - Heroes of Jin Yong is built using Unreal Engine 5 and features a large-scale open world of 960 square kilometers, recreating characters and locations from 15 classic Wuxia novels [3] - The game emphasizes player freedom, diverse gameplay systems, and rich storytelling, aiming to deliver a cinematic and immersive experience [3] Strategic Importance - Heroes of Jin Yong is a high-investment strategic project for CreateAI, alongside the global IP The Three-Body Problem, forming the core of the company's content portfolio [4] - The company is committed to promoting Chinese culture globally and leveraging technological advancements to enhance its storytelling capabilities [4]

See if any of these high-yield stocks are worth buying.The Nasdaq stock exchange isn't known for dividend stocks. It's more associated with tech stocks, which don't generally pay dividends until they've reached maturity, and even then, they tend to be small.However, there are still some Nasdaq stocks to offer strong dividends. Using the Nasdaq-100 index of the 100 largest Nasdaq stocks to simplify things, here are the top three dividend payers in the index. 1. Kraft Heinz (dividend yield: 6.5%)Packaged food ...

Lamb Weston Holdings, Inc. (NYSE:LW) will release earnings results for its second quarter before the opening bell on Friday, Dec. 19.Analysts expect the Eagle, Idaho-based company to report quarterly earnings at 65 cents per share, down from 66 cents per share in the year-ago period. The consensus estimate for Lamb Weston's quarterly revenue is $1.59 billion. Last year, it reported $1.6 billion in revenue, according to Benzinga Pro.On Sept. 30, Lamb Weston posted first-quarter fiscal 2026 net sales of $1.66 ...

Core Insights - Lamb Weston Holdings, Inc. is set to release its second-quarter earnings results on December 19, with analysts expecting earnings of 65 cents per share, a slight decrease from 66 cents per share in the same period last year [1] - The consensus estimate for quarterly revenue is $1.59 billion, down from $1.6 billion reported last year [1] Financial Performance - For the first quarter of fiscal 2026, Lamb Weston reported net sales of $1.66 billion, a slight increase from $1.65 billion a year earlier and exceeding the estimate of $1.62 billion [2] - Shares of Lamb Weston closed at $59.33, reflecting a 0.2% decline [2] Analyst Ratings - B of A Securities analyst maintained a Neutral rating and raised the price target from $60 to $66 [4] - Stifel analyst maintained a Hold rating and reduced the price target from $63 to $56 [4] - Jefferies analyst maintained a Buy rating but lowered the price target from $80 to $75 [4] - Barclays analyst maintained an Overweight rating and cut the price target from $87 to $69 [4]

Company Overview - Guerbet is a global leader in medical imaging, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging [5] - The company has been a pioneer in contrast agents for 98 years and employs 2,905 people worldwide [6] - Guerbet dedicated 9% of its revenue to Research & Development across four centers in France and the United States [6] - In 2024, Guerbet achieved €841 million in revenue [6] Appointment of François Convenant - François Convenant has been appointed as Senior Vice President of Interventional Radiology and will join the Guerbet Group's Executive Committee [1] - He joined Guerbet in September 2018 and has extensive international experience in the healthcare and medical device sector [2] - His previous roles involved management positions at leading companies, focusing on innovation and growth in surgical solutions and interventional devices [2] Interventional Radiology Insights - Interventional radiology is a rapidly expanding medical specialty that combines advanced imaging with minimally invasive therapeutic procedures [3] - This field is experiencing rapid growth due to an aging population and increasing demand for less invasive treatments [3] - Technological innovations, including AI, robotics, and precision imaging, are enhancing the safety and effectiveness of procedures [3] - The economic and clinical impact includes reduced costs related to complications and improved quality of life for patients [4] Guerbet's Mission and Offerings - Guerbet aims to meet the needs of healthcare institutions and practitioners by providing integrated and innovative solutions [4] - The company combines drugs, medical devices, services, and technologies, supported by dedicated training programs to enhance clinical practices [4]

WH Smith is being investigated by the City watchdog after the company revealed accounting failures in its US operations.The Financial Conduct Authority (FCA) said: "The investigation concerns potential breaches of UK Listing Principles and Rules and Disclosure and Transparency Rules in relation to the matters announced by WH Smith PLC on 19 November 2025." On that day WH Smith revealed that Carl Cowling, its chief executive of six years who had presided over the sale of the company's UK high street business ...

The In terms of returns, Why Global Diversification Matters More Than EverMarket cycles do not move in tandem across geographies. While Indian markets remain a compelling long-term growth story, global exposure—especially to the US—can help investors balance risk, reduce portfolio volatility, and access sectors that are either underrepresented or unavailable domestically.Investment flows into overseas equities rebounded sharply, rising from USD 152 million in August to USD 279 million in September. (Refere ...

Vision Marine Technologies Inc. (NASDAQ:VMAR) shares jumped 16.67% in after-hours trading to $0.28 on Thursday after pricing a best-efforts public offering.Check out the current price of VMAR stock here.In a best-efforts public offering, the underwriter agrees to sell as many shares as possible without guaranteeing a specific amount of proceeds.Offering DetailsThe marine technology and retail company priced 32 million units at $0.30 each, targeting gross proceeds of $9.6 million before fees, according to a ...

Core Viewpoint - BBVA has announced a share buyback program amounting to 3.96 billion euros ($4.64 billion), marking the largest buyback in the bank's history [1] Company Summary - The share buyback reflects BBVA's strong financial position and commitment to returning value to shareholders [1] - This buyback program is significant in size, indicating the bank's confidence in its future performance and capital management strategy [1]

What is going wrong for Nike. I mean, the problem here is the pace of change. And you're really seeing investors disappointed in how fast the turnaround is happening.So there are really two persistent sore points here that we saw from yesterday's results. The first being Converse. The iconic brand sales are down 30%.For a long time, the company has relied on sales of its iconic Chuck Taylor sneakers. But unfortunately, you know, consumers are just not as interested in the sneaker as they were before. The ot ...